, the ALL-BFM study group from, vol.24, 1981.

D. A. Sipkins, X. Wei, J. W. Wu, J. M. Runnels, D. Côté et al., In vivo imaging of 986 specialized bone marrow endothelial microdomains for tumour engraftment, Nature, vol.987, pp.969-73, 2005.

A. Colmone, M. Amorim, A. L. Pontier, S. Wang, E. Jablonski et al., Leukemic 989 Cells Create Bone Marrow Niches That Disrupt the Behavior of Normal Hematopoietic 990 Progenitor Cells, Science, vol.322, pp.1861-1866, 2008.

C. Duan, J. Shi, J. Chen, B. Wang, Y. Yu et al., Leukemia Propagating Cells 992 Rebuild an Evolving Niche in Response to Therapy, Cancer Cell, vol.25, pp.778-93, 2014.

S. Ebinger, E. Z. Özdemir, C. Ziegenhain, S. Tiedt, C. Alves et al., 995 Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic 996

, Leukemia. Cancer Cell, vol.30, pp.849-62, 2016.

A. Roy, A. Cargill, S. Love, A. V. Moorman, S. Stoneham et al., Outcome after first 998 relapse in childhood acute lymphoblastic leukaemia -lessons from the United Kingdom R2 999 trial, Br J Haematol, vol.130, pp.67-75, 2005.

M. M. Hudson, L. S. Frankel, J. Mullins, and D. A. Swanson, Diagnostic value of surgical 1001 testicular biopsy after therapy for acute lymphocytic leukemia, J Pediatr, vol.107, pp.50-53, 1985.

J. Tiedemann, J. M. Chessells, and R. M. Sandland, Isolated testicular relapse in boys with 1003 acute lymphoblastic leukaemia: treatment and outcome, Br Med J Clin Res Ed, vol.1004, pp.1614-1620, 1982.

C. H. Pui, G. V. Dahl, W. P. Bowman, B. N. Rao, M. Abromowitch et al., Elective 1006 testicular biopsy during chemotherapy for childhood leukaemia is of no clinical value, Lancet 1007 Lond Engl, vol.2, pp.410-412, 1985.

J. J. Ortega, G. Javier, and N. Torán, Testicular infiltrates in children with acute lymphoblastic 1009 leukemia: a prospective study, Pediatr Blood Cancer, vol.12, pp.386-393, 1984.

K. Y. Wong, E. T. Ballard, F. H. Strayer, C. T. Kisker, and B. C. Lampkin, Clinical and occult 1011 testicular leukemia in long-term survivors of acute lymphoblastic leukemia, J Pediatr, vol.1012, pp.569-574, 1980.

F. P. Prince, N. F. Palmer, and W. A. Newton, Ultrastructural criteria in evaluating leukemic 1014 infiltration in prepubertal testicular biopsies, Pediatr Pathol, vol.5, pp.17-29, 1986.

K. Jahnukainen, M. Hou, C. Petersen, B. Setchell, and O. Söder, Intratesticular 1016 Transplantation of Testicular Cells from Leukemic Rats Causes Transmission of Leukemia

, Cancer Res, vol.61, pp.706-716, 2001.

K. Jahnukainen, I. Morris, S. Roe, T. T. Salmi, A. Mäkipernaa et al., A rodent model 1019 for testicular involvement in acute lymphoblastic leukaemia, Br J Cancer, vol.67, p.885, 1993.

H. Jackson, N. C. Jackson, M. Bock, and M. Lendon, Testicular invasion and relapse and 1021 meningeal involvement in a rat T-cell leukaemia, Br J Cancer, vol.50, pp.617-641, 1984.

H. Jackson, N. C. Jackson, M. Bock, and M. Lendon, Testicular relapse in acute lymphoblastic 1023 leukaemia: studies with an experimental mouse model, Br J Cancer, vol.49, pp.73-81, 1984.

L. E. Ginsberg and N. E. Leeds, Neuroradiology of leukemia, AJR Am J Roentgenol, vol.1067, pp.525-559, 1995.

E. Ulu, H. G. Töre, A. Bayrak, D. Güngör, and M. Coskun, MRI of central nervous system 1069 abnormalities in childhood leukemia, Diagn Interv Radiol, vol.15, p.86, 2009.

K. Isome, K. Matsubara, T. Taki, H. Nigami, K. Yura et al., Spinal Cord 1071 Compression by Epidural Involvement Over 21 Vertebral Levels in Acute Lymphoblastic 1072 Leukemia, J Pediatr Hematol Oncol, vol.33, pp.153-160, 2011.

H. Yao, T. T. Price, G. Cantelli, B. Ngo, M. J. Warner et al., Leukaemia hijacks a 1074 neural mechanism to invade the central nervous system, Nature, vol.560, pp.55-60, 1075.

I. Cunningham, Extramedullary sites of leukemia relapse after transplant, Lymphoma, vol.47, pp.1754-67, 1077.

I. Cunningham, A clinical review of breast involvement in acute leukemia, Lymphoma, vol.47, pp.2517-2543, 1079.

I. Cunningham, A basis for updating our approach to resistant acute leukemia, Am J 1081 Hematol, vol.87, pp.251-258, 2012.

I. Cunningham and B. Kohno, 18FDG-PET/CT: 21st century approach to leukemic tumors 1083 in 124 cases, Am J Hematol, vol.91, pp.379-84, 2016.

M. Karbasian-esfahani, P. H. Wiernik, M. Yeddu, and L. Abebe, Leukemic infiltration of the 1085 breast in acute lymphocytic leukemia (ALL), Hematol Amst Neth, vol.13, pp.101-107, 1086.

E. Sison and P. Brown, The bone marrow microenvironment and leukemia: biology and 1088 therapeutic targeting, Expert Rev Hematol, vol.4, pp.271-83, 2011.

S. J. Morrison and D. T. Scadden, The bone marrow niche for haematopoietic stem cells, Nature, vol.505, pp.327-361, 1090.

L. M. Calvi and D. C. Link, The hematopoietic stem cell niche in homeostasis and disease, Blood, vol.126, pp.2443-51, 1092.

F. Chiarini, A. Lonetti, C. Evangelisti, F. Buontempo, E. Orsini et al.,

, Advances in understanding the acute lymphoblastic leukemia bone marrow 1095 microenvironment: From biology to therapeutic targeting, Biochim Biophys Acta BBA -Mol, p.1096

, Cell Res, vol.1863, pp.449-63, 2016.

G. M. Crane, E. Jeffery, and S. J. Morrison, Adult haematopoietic stem cell niches, Nat Rev, vol.17, pp.573-90, 1098.

R. Schofield, The relationship between the spleen colony-forming cell and the 1100 haemopoietic stem cell, Blood Cells, vol.4, pp.7-25, 1978.

L. M. Calvi and D. C. Link, The hematopoietic stem cell niche in homeostasis and disease, Blood, vol.126, pp.2443-51, 1102.

Y. Tabe and M. Konopleva, Advances in understanding the leukaemia microenvironment

, Br J Haematol, vol.164, pp.767-78, 2014.

V. Hira, C. Van-noorden, H. E. Carraway, J. P. Maciejewski, and R. J. Molenaar,

I. Kazanis, J. Lathia, L. Moss, and C. Ffrench-constant, The neural stem cell 1110 microenvironment, 2008.

O. Basak and V. Taylor, Stem cells of the adult mammalian brain and their niche, Cell Mol, vol.66, pp.1057-72, 1112.

R. Lin and L. Iacovitti, Classic and novel stem cell niches in brain homeostasis and repair

, Brain Res, vol.1628, pp.327-369, 2015.

J. M. Oatley and R. L. Brinster, THE GERMLINE STEM CELL NICHE UNIT IN 1116 MAMMALIAN TESTES, Physiol Rev, vol.92, pp.577-95, 2012.

D. D. Mruk and C. Y. Cheng, The Mammalian Blood-Testis Barrier: Its Biology and 1118 Regulation, Endocr Rev, vol.36, pp.564-91, 2015.

A. Descot and T. Oskarsson, The molecular composition of the metastatic niche, Exp Cell, vol.319, pp.1679-86, 1120.

D. Hanahan and R. A. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.1122, pp.646-74, 2011.

F. Guo, Y. Wang, J. Liu, S. C. Mok, F. Xue et al., CXCL12/CXCR4: a symbiotic 1124 bridge linking cancer cells and their stromal neighbors in oncogenic communication 1125 networks, Oncogene, 2015.

T. Sugiyama, H. Kohara, M. Noda, and T. Nagasawa, Maintenance of the Hematopoietic 1127 Stem Cell Pool by CXCL12-CXCR4 Chemokine Signaling in Bone Marrow Stromal Cell 1128 Niches, Immunity, vol.25, pp.977-88, 2006.

A. Dar, P. Goichberg, V. Shinder, A. Kalinkovich, O. Kollet et al., Chemokine 1130 receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by 1131 bone marrow endothelial and stromal cells, Nat Immunol, vol.6, pp.1038-1084, 1132.

S. Scala, Molecular Pathways: Targeting the CXCR4-CXCL12 Axis-Untapped 1134 Potential in the Tumor Microenvironment, Clin Cancer Res, vol.21, pp.4278-85, 1135.

X. Sun, G. Cheng, M. Hao, J. Zheng, X. Zhou et al.,

, Chemokine Axis and Cancer Progression, Cancer Metastasis Rev, vol.29, pp.709-731, 1138.

M. V. Barbolina, M. Kim, Y. Liu, J. Shepard, A. Belmadani et al.,

, Microenvironmental Regulation of Chemokine (C-X-C-motif) Receptor 4 in Ovarian 1141 Carcinoma, Mol Cancer Res MCR, vol.8, pp.653-64, 2010.

Y. Kasagi, Y. Harada, Y. Morodomi, T. Iwai, S. Saito et al., Peritoneal 1143 Dissemination Requires an Sp1-Dependent CXCR4/CXCL12 Signaling Axis and 1144 Extracellular Matrix-Directed Spheroid Formation, Cancer Res, vol.76, pp.347-57, 1145.

F. Ogawa, H. Amano, K. Eshima, Y. Ito, Y. Matsui et al., Prostanoid induces 1147 premetastatic niche in regional lymph nodes, J Clin Invest, vol.124, pp.4882-94, 1148.

K. Nishii, N. Katayama, H. Miwa, M. Shikami, M. Masuya et al., Survival of 1150 human leukaemic B-cell precursors is supported by stromal cells and cytokines: association 1151 with the expression of bcl-2 protein, Br J Haematol, vol.105, pp.701-711, 1999.

J. Juarez, K. F. Bradstock, D. J. Gottlieb, and L. J. Bendall, Effects of inhibitors of the 1153 chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro, Leukemia, vol.1154, pp.1294-300, 2003.

D. C. Gilbert, I. Chandler, A. Mcintyre, N. C. Goddard, R. Gabe et al., Clinical 1156 and biological significance of CXCL12 and CXCR4 expression in adult testes and germ cell 1157 tumours of adults and adolescents, J Pathol, vol.217, pp.94-102, 2009.

S. C. Mciver, K. L. Loveland, S. D. Roman, B. Nixon, R. Kitazawa et al., The 1159 chemokine CXCL12 and its receptor CXCR4 are implicated in human seminoma metastasis, Andrology, vol.1, pp.517-546, 1160.

B. Westernströer, D. Langenstroth, S. Kliesch, B. Troppmann, K. Redmann et al., Developmental expression patterns of chemokines CXCL11, CXCL12 and their receptor 1163 CXCR7 in testes of common marmoset and human, Cell Tissue Res, vol.361, pp.885-98, 1164.

I. Tröndle, B. Westernströer, J. Wistuba, N. Terwort, S. Schlatt et al., Irradiation 1166 affects germ and somatic cells in prepubertal monkey testis xenografts, Mol Hum Reprod, vol.1167, pp.141-54, 2017.

M. Arnaud, A. Vallée, G. Robert, J. Bonneau, C. Leroy et al., CD9, a 1169 key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated 1170 migration via RAC1 signaling, Blood, vol.126, pp.1802-1814, 2015.

H. Kobayashi, M. Urashima, Y. Hoshi, H. Uchiyama, K. Fujisawa et al.,

, Testicular morphological changes in children with acute lymphoblastic leukemia following 1174 chemotherapy, Acta Paediatr Jpn Overseas Ed, vol.38, pp.640-643, 1996.

A. Guyon, CXCL12 chemokine and its receptors as major players in the interactions 1176 between immune and nervous systems, Front Cell Neurosci, vol.8, 1177.

Q. Ma, D. Jones, P. R. Borghesani, R. A. Segal, T. Nagasawa et al., Impaired 1179 B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4-and 1180 SDF-1-deficient mice, Proc Natl Acad Sci U S A, vol.95, pp.9448-53, 1998.

M. Lu, E. A. Grove, and R. J. Miller, Abnormal development of the hippocampal dentate gyrus 1182 in mice lacking the CXCR4 chemokine receptor, Proc Natl Acad Sci U S A, vol.99, pp.7090-7095, 1183.

F. Lazarini, T. N. Tham, P. Casanova, F. Arenzana-seisdedos, and M. Dubois-dalcq, Role of 1185 the ?-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central 1186 nervous system, Glia, vol.42, pp.139-187, 2003.

S. Yang, L. C. Edman, J. A. Sánchez-alcañiz, N. Fritz, S. Bonilla et al.,

, Cxcl12/Cxcr4 signaling controls the migration and process orientation of A9-A10 1189 dopaminergic neurons, Development, vol.140, pp.4554-64, 2013.

R. K. Stumm, J. Rummel, V. Junker, C. Culmsee, M. Pfeiffer et al., A Dual 1191 Role for the SDF-1/CXCR4 Chemokine Receptor System in Adult Brain

, Expression Modulates CXCR4-Dependent Neuronal Plasticity and 1193

, Cerebral Leukocyte Recruitment after Focal Ischemia, J Neurosci, vol.22, pp.5865-78, 2002.

A. Bajetto, R. Bonavia, S. Barbero, P. Piccioli, A. Costa et al., Glial and 1195 Neuronal Cells Express Functional Chemokine Receptor CXCR4 and Its Natural Ligand 1196 Stromal Cell-Derived Factor 1, J Neurochem, vol.73, pp.2348-57, 1999.

E. E. Mccandless, Q. Wang, B. M. Woerner, J. M. Harper, and R. S. Klein, CXCL12 Limits 1199 Inflammation by Localizing Mononuclear Infiltrates to the Perivascular Space during 1200 Experimental Autoimmune Encephalomyelitis, J Immunol, vol.177, pp.8053-64, 1201.

E. E. Mccandless, L. Piccio, B. M. Woerner, R. E. Schmidt, J. B. Rubin et al.,

, Pathological Expression of CXCL12 at the Blood-Brain Barrier Correlates with Severity of 1204 Multiple Sclerosis, Am J Pathol, vol.172, pp.799-808, 2008.

B. Jost-tanja-rezzonico, R. Chiara, R. Enrico, and . Andrea, Perruzza 1206 Lisa, Omodho Lorna, et al. Role of CXCR4-mediated bone marrow colonization in CNS 1207 infiltration by T cell acute lymphoblastic leukemia, J Leukoc Biol, vol.99, pp.1077-87, 1208.

A. Alsadeq, H. Fedders, C. Vokuhl, N. M. Belau, M. Zimmermann et al.,

, The role of ZAP70 kinase in acute lymphoblastic leukemia infiltration into the central nervous 1211 system, Haematologica, vol.102, pp.346-55, 2017.

R. Crazzolara, A. Kreczy, G. Mann, A. Heitger, G. Eibl et al., High expression 1213 of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood 1214 acute lymphoblastic leukaemia, Br J Haematol, vol.115, pp.545-53, 2001.

J. Juarez, A. D. Pena, R. Baraz, J. Hewson, M. Khoo et al., CXCR4 antagonists 1216 mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit 1217 engraftment, Leukemia, vol.21, pp.1249-57, 2007.

I. Kato, A. Niwa, T. Heike, H. Fujino, M. K. Saito et al., , p.1219

, Hepatic Niche Harboring Human Acute Lymphoblastic Leukemic Cells via the SDF-1220

/. Axis, PLOS ONE, vol.6, 2011.

Z. Ivanovic, Hypoxia or in situ normoxia: The stem cell paradigm, J Cell Physiol, vol.1222, pp.271-276, 2009.

P. Eliasson and J. Jönsson, The hematopoietic stem cell niche: Low in oxygen but a nice 1224 place to be, J Cell Physiol, vol.222, pp.17-22, 2010.

Y. Ishikawa and T. Ito, Kinetics of hemopoietic stem cells in a hypoxic culture, Eur J 1226 Haematol, vol.40, pp.126-135, 1988.

D. C. Chow, L. A. Wenning, W. M. Miller, and E. T. Papoutsakis, Modeling pO(2) distributions in 1228 the bone marrow hematopoietic compartment. I. Krogh's model, Biophys J, vol.81, pp.675-84, 1229.

D. C. Chow, L. A. Wenning, W. M. Miller, and E. T. Papoutsakis, Modeling pO(2) distributions in 1231 the bone marrow hematopoietic compartment. II. Modified Kroghian models, Biophys J, vol.1232, pp.75733-75738, 2001.

J. A. Spencer, F. Ferraro, E. Roussakis, A. Klein, J. Wu et al., Direct 1234 measurement of local oxygen concentration in the bone marrow of live animals, Nature, vol.1235, pp.269-73, 2014.

K. Parmar, P. Mauch, J. Vergilio, R. Sackstein, and J. D. Down, Distribution of 1237 hematopoietic stem cells in the bone marrow according to regional hypoxia, Proc Natl Acad, vol.104, pp.5431-5437, 1238.

Z. Ivanovic, F. Hermitte, P. Brunet-de-la-grange, B. Dazey, F. Belloc et al., Simultaneous maintenance of human cord blood SCID-repopulating cells and expansion of 1241 committed progenitors at low O2 concentration (3%), Stem Cells Dayt Ohio, vol.22, pp.716-740, 1240.

A. V. Guitart, M. Hammoud, D. Sbarba, P. Ivanovic, Z. Praloran et al., Slow-1244 cycling/quiescence balance of hematopoietic stem cells is related to physiological gradient of 1245 oxygen, Exp Hematol, vol.38, pp.847-51, 2010.

M. Kova?evi?-filipovi?, M. Petakov, F. Hermitte, C. Debeissat, A. Krsti? et al.,

, IL-6) and low O2 concentration (1%) synergize to improve the maintenance of 1248 hematopoietic stem cells (pre-CFC), J Cell Physiol, vol.212, issue.6, pp.68-75, 2007.

F. Hermitte, P. Brunet-de-la-grange, F. Belloc, V. Praloran, and Z. Ivanovic, Very low O2 1250 concentration (0.1%) favors G0 return of dividing CD34+ cells, Stem Cells Dayt Ohio, vol.1251, pp.65-73, 2006.

C. Nombela-arrieta, G. Pivarnik, B. Winkel, K. J. Canty, B. Harley et al.,

, Quantitative Imaging of Hematopoietic Stem and Progenitor Cell localization and hypoxic 1254 status in the Bone Marrow microenvironment, Nat Cell Biol, vol.15, pp.533-576, 1255.

B. Philip, K. Ito, R. Moreno-sánchez, and S. J. Ralph, HIF expression and the role of hypoxic 1257 microenvironments within primary tumours as protective sites driving cancer stem cell 1258 renewal and metastatic progression, Carcinogenesis, vol.34, pp.1699-707, 1259.

A. Chen, J. Sceneay, N. Gödde, T. Kinwel, S. Ham et al., Intermittent 1261 hypoxia induces a metastatic phenotype in breast cancer, Oncogene, 1262.

S. C. Hanna, B. Krishnan, S. T. Bailey, S. J. Moschos, P. Kuan et al., HIF1? 1264 and HIF2? independently activate SRC to promote melanoma metastases, J Clin Invest, vol.1265, pp.2078-93, 2013.

J. Benito, Y. Shi, B. Szymanska, H. Carol, I. Boehm et al., Pronounced hypoxia in 1267 models of murine and human leukemia: high efficacy of hypoxia

, PloS One, vol.6, 2011.

Z. Dong-feng, L. Ting, C. Cheng, Z. Xi, L. Xue et al., Silencing HIF-1? 1270 reduces the adhesion and secretion functions of acute leukemia hBMSCs, Braz J Med Biol 1271 Res, vol.45, pp.906-918, 2012.

S. Jamieson, Y. Gu, D. M. Manesh, J. El-hoss, D. Jing et al., A novel 1273 fluorometric assay for aldo-keto reductase 1C3 predicts metabolic activation of the nitrogen 1274 mustard prodrug PR-104A in human leukaemia cells, Biochem Pharmacol, vol.88, pp.36-45, 1275.

J. Benito, Z. Zeng, M. Konopleva, and W. R. Wilson, Targeting hypoxia in the leukemia 1277 microenvironment, Int J Hematol Oncol, vol.2, pp.279-288, 2013.

M. Konopleva, P. F. Thall, C. A. Yi, G. Borthakur, A. Coveler et al., Phase 1279 I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid 1280 leukemia and acute lymphoblastic leukemia, Haematologica, vol.100, pp.927-961, 1281.

T. Badar, D. R. Handisides, J. M. Benito, M. A. Richie, G. Borthakur et al., A 1283 Phase I Study of Evofosfamide, an Investigational Hypoxia-Activated Prodrug, in Patients 1284 with Advanced Leukemia, Am J Hematol, vol.91, pp.800-805, 2016.

J. Benito, M. S. Ramirez, N. Z. Millward, J. Velez, K. G. Harutyunyan et al., , p.1286

, Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia 1287 Models, Clin Cancer Res, vol.22, pp.1687-98, 2016.

L. Schito, S. Rey, and M. Konopleva, Integration of hypoxic HIF-? signaling in blood 1289 cancers, Oncogene, vol.36, pp.5331-5371, 2017.

O. Frolova, I. Samudio, J. M. Benito, R. Jacamo, S. M. Kornblau et al., 1291 Regulation of HIF-1? signaling and chemoresistance in acute lymphocytic leukemia under 1292 hypoxic conditions of the bone marrow microenvironment, Cancer Biol Ther, vol.13, pp.858-1293, 2012.

C. Petit, F. Gouel, I. Dubus, C. Heuclin, K. Roget et al., Hypoxia promotes 1295 chemoresistance in acute lymphoblastic leukemia cell lines by modulating death signaling 1296 pathways, BMC Cancer, vol.16, p.746, 2016.

M. J. Free and J. Schluntz, Respiratory Gas Tensions in Tissues and Fluids of the Male 1298 Rat Reproductive Tract, 1976.

T. Klotz, R. Vorreuther, A. Heidenreich, J. Zumbé, and U. Engelmann, Testicular tissue 1300 oxygen pressure, J Urol, vol.155, pp.1488-91, 1996.

G. Gruber, M. Carlet, E. Türtscher, B. Meister, J. Irving et al., Levels of 1302 glucocorticoid receptor and its ligand determine sensitivity and kinetics of glucocorticoid-1303 induced leukemia apoptosis, Leukemia, vol.23, pp.820-823, 2009.

P. Yarnell, G. Charlton, C. R. Merril, F. Ghiardi, and A. K. Ommaya, Dynamics of oxygen 1305 tension in the cisternal cerebrospinal fluid of the rhesus monkey, J Neurosurg, vol.27, pp.515-1306, 1967.

H. Kishikawa, K. Iwatsuki, S. Fujimoto, and A. Umeda, Body fluid oxygen tension and 1308 prognosis in patients with ruptured aneurysm, Stroke, vol.10, pp.560-563, 1979.

M. Sharan, E. P. Vovenko, A. Vadapalli, A. S. Popel, and R. N. Pittman, Experimental and 1310 theoretical studies of oxygen gradients in rat pial microvessels, J Cereb Blood Flow Metab, p.1311

, Off J Int Soc Cereb Blood Flow Metab, vol.28, pp.1597-604, 2008.

I. Kato, Y. Nishinaka, M. Nakamura, A. U. Akarca, A. Niwa et al., Hypoxic 1313 adaptation of leukemic cells infiltrating the CNS affords a therapeutic strategy targeting 1314 VEGFA, Blood, vol.129, pp.3126-3135, 2017.

V. Münch, L. Trentin, J. Herzig, S. Demir, F. Seyfried et al., Central nervous 1316 system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial 1317 growth factor, Blood, vol.130, pp.643-54, 2017.

Y. Tang, F. Jiang, L. Guo, M. Si, and X. Jiao, Expression and significance of vascular 1319 endothelial growth factor A and C in leukemia central nervous system metastasis, Leuk Res, vol.1320, pp.359-66, 2013.

S. Izraeli and C. Eckert, Targeted therapy of CNS leukemia?, Blood, vol.130, 2017.

S. D. Lyman, S. Jacobsen, and F. Ligand, Stem/Progenitor Cell 1324 Factors With Overlapping Yet Distinct Activities, Blood, vol.91, pp.1101-1135, 1998.

L. K. Ashman, The biology of stem cell factor and its receptor C-kit, Int J Biochem Cell, vol.31, pp.1037-51, 1326.

J. Lennartsson and L. Rönnstrand, Stem Cell Factor Receptor/c-Kit: From Basic Science to 1328 Clinical Implications, Physiol Rev, vol.92, pp.1619-1668, 2012.

L. Ding, T. L. Saunders, G. Enikolopov, and S. J. Morrison, Endothelial and perivascular cells 1330 maintain haematopoietic stem cells, Nature, vol.481, pp.457-62, 2012.

E. J. Huang, K. H. Nocka, J. Buck, and P. Besmer, Differential expression and processing of 1332 two cell associated forms of the kit-ligand: KL-1 and KL-2, Mol Biol Cell, vol.3, pp.349-62, 1992.

J. G. Flanagan, D. C. Chan, and P. Leder, Transmembrane form of the kit ligand growth factor 1334 is determined by alternative splicing and is missing in the SId mutant, Cell, vol.64, pp.1025-1060, 1335.

T. Kinashi and T. A. Springer, Steel factor and c-kit regulate cell-matrix adhesion, Blood, vol.1337, pp.1033-1041, 1994.

R. L. Driessen, H. M. Johnston, and S. K. Nilsson, Membrane-bound stem cell factor is a key 1339 regulator in the initial lodgment of stem cells within the endosteal marrow region, Hematol, vol.31, pp.1284-91, 1340.

N. Okumura, K. Tsuji, Y. Ebihara, I. Tanaka, N. Sawai et al., Chemotactic and 1342 chemokinetic activities of stem cell factor on murine hematopoietic progenitor cells, Blood, vol.1343, pp.4100-4108, 1996.

B. Huang, Z. Lei, G. Zhang, D. Li, C. Song et al., SCF-mediated mast cell 1345 infiltration and activation exacerbate the inflammation and immunosuppression in tumor 1346 microenvironment, Blood, vol.112, pp.1269-79, 2008.

M. I. Figueira, H. J. Cardoso, S. Correia, C. J. Maia, and S. Socorro, The stem cell factor 1348 (SCF)/c-KIT system in carcinogenesis of reproductive tissues: What does the hormonal 1349 regulation tell us?, Cancer Lett, vol.405, pp.10-21, 2017.

M. Miettinen and L. J. Kit, CD117): a review on expression in normal and neoplastic 1351 tissues, and mutations and their clinicopathologic correlation, Appl Immunohistochem Mol, p.1352

, Morphol AIMM, vol.13, pp.205-225, 2005.

X. Zhou, M. N. Edmonson, M. R. Wilkinson, A. Patel, G. Wu et al., Exploring 1354 genomic alteration in pediatric cancer using ProteinPaint, Nat Genet, vol.48, pp.4-6, 1355.

L. Debaize, H. Jakobczyk, S. Avner, J. Gaudichon, A. Rio et al., 1357 Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the 1358 oncogene c-KIT and amplifies cell proliferation, Nucleic Acids Res, vol.30, issue.21, pp.11214-1359, 2018.

B. Muciaccia, C. Sette, M. P. Paronetto, M. Barchi, S. Pensini et al., Expression of a truncated form of KIT tyrosine kinase in human spermatozoa correlates with 1362 sperm DNA integrity, Hum Reprod, vol.25, pp.2188-202, 1361.

S. K. Unni, D. N. Modi, S. G. Pathak, J. V. Dhabalia, and D. Bhartiya, Stage-specific Localization 1364 and Expression of c-kit in the Adult Human Testis, J Histochem Cytochem, vol.57, pp.861-870, 1365.

R. A. Fox, M. Sigman, and K. Boekelheide, Transmembrane versus soluble stem cell factor 1367 expression in human testis, J Androl, vol.21, pp.579-85, 2000.

B. Motro, D. Van-der-kooy, J. Rossant, A. Reith, and A. Bernstein, Contiguous patterns of c-1369 kit and steel expression: analysis of mutations at the W and Sl loci, Dev Camb Engl, vol.1370, pp.1207-1228, 1991.

J. I. Sandlow, H. Feng, and S. A. , Localization and expression of the c-Kit receptor 1372 protein in human and rodent testis and sperm, Urology, vol.49, issue.96, pp.494-497, 1997.

H. Stoop, F. Honecker, G. Van-de-geijn, A. Gillis, M. C. Cools et al., 1375 Stem cell factor as a novel diagnostic marker for early malignant germ cells, J Pathol, vol.1376, pp.43-54, 2008.

T. Strohmeyer, D. Reese, M. Press, R. Ackermann, M. Hartmann et al., Expression 1378 of the c-kit Proto-Oncogene and Its Ligand Stem Cell Factor (SCF) in Normal and Malignant 1379 Human Testicular Tissue, J Urol, vol.153, pp.511-516, 1995.

P. Guijarro, Y. Wang, Y. Ying, Y. Yao, X. Jieyi et al., In vivo knockdown of ckit 1381 impairs neuronal migration and axonal extension in the cerebral cortex, Dev Neurobiol, vol.1382, pp.871-87, 2013.

B. Kallmann, S. Wagner, V. Hummel, M. Buttmann, A. Bayas et al., Characteristic gene expression profile of primary human cerebral endothelial cells, FASEB J, vol.1385, pp.589-91, 1384.

S. E. Schutzer, T. Liu, B. H. Natelson, T. E. Angel, A. A. Schepmoes et al., Establishing the Proteome of Normal Human Cerebrospinal Fluid, PLOS ONE, vol.1388, p.10980, 1387.

A. Bastos, C. B. Blunck, M. Emerenciano, and E. Gimba, Osteopontin and their roles in 1390 hematological malignancies: Splice variants on the new avenues, Cancer Lett, vol.408, pp.138-1391, 2017.

L. A. Shevde and R. S. Samant, Role of osteopontin in the pathophysiology of cancer, Matrix, vol.1393

, Biol J Int Soc Matrix Biol, vol.37, pp.131-172, 2014.

J. M. Oatley, M. J. Oatley, M. R. Avarbock, J. W. Tobias, and R. L. Brinster, Colony stimulating 1395 factor 1 is an extrinsic stimulator of mouse spermatogonial stem cell self-renewal. Dev Camb, Engl, vol.136, pp.1191-1200, 1396.

T. Defalco, S. J. Potter, A. V. Williams, B. Waller, M. J. Kan et al., Macrophages 1398 Contribute to the Spermatogonial Niche in the Adult Testis, Cell Rep, vol.12, pp.1107-1126, 1399.

I. Ushach and A. Zlotnik, Biological role of granulocyte macrophage colony-stimulating 1401 factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid 1402 lineage, J Leukoc Biol, vol.100, pp.481-490, 2016.

V. Chitu, S. Gokhan, S. Nandi, M. F. Mehler, and E. R. Stanley, Emerging Roles for CSF-1 1404 Receptor and its Ligands in the Nervous System, Trends Neurosci, vol.39, pp.378-93, 1405.

K. G. Roberts, Y. Li, D. Payne-turner, R. C. Harvey, Y. Yang et al., Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia, N Engl J Med, vol.1408, pp.1005-1020, 1407.

H. Lilljebjörn, H. Ågerstam, C. Orsmark-pietras, M. Rissler, H. Ehrencrona et al., RNA-seq identifies clinically relevant fusion genes in leukemia including a novel 1411 MEF2D/CSF1R fusion responsive to imatinib, Leukemia, vol.28, pp.977-986, 1412.

C. Schwab, R. Andrews, L. Chilton, A. Elliott, S. Richardson et al., SSBP2-1414 CSF1R Is a Recurrent Fusion in B-Other Acute Lymphoblastic Leukaemia with Variable 1415 Clinical Outcome, Blood, vol.124, pp.3773-3773, 2014.

S. Iwamoto, K. Mihara, J. R. Downing, C. Pui, and D. Campana, Mesenchymal cells 1417 regulate the response of acute lymphoblastic leukemia cells to asparaginase, J Clin Invest, vol.117, pp.1049-57, 1418.

K. Fung, R. Liang, and G. Chan, Vincristine but not imatinib could suppress 1420 mesenchymal niche's support to lymphoid leukemic cells, Leuk Lymphoma, vol.51, pp.515-537, 1421.

S. Paget, THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF 1423 THE BREAST, The Lancet, vol.133, pp.571-574, 1889.

I. J. Fidler and G. L. Nicolson, Organ selectivity for implantation survival and growth of B16 1425 melanoma variant tumor lines, J Natl Cancer Inst, vol.57, pp.1199-202, 1976.

H. Peinado, H. Zhang, I. R. Matei, B. Costa-silva, A. Hoshino et al., Pre-1427 metastatic niches: organ-specific homes for metastases, Nat Rev Cancer, vol.17, pp.302-319, 1428.

D. Duarte, E. D. Hawkins, and C. L. Celso, The interplay of leukemia cells and the bone 1430 marrow microenvironment, Blood, vol.131, pp.1507-1518, 2018.

B. Boyerinas, M. Zafrir, A. E. Yesilkanal, T. T. Price, E. M. Hyjek et al., Adhesion to 1432 osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy, Blood, vol.1433, pp.4821-4852, 2013.

. Rooij-b-de, R. Polak, . Berk-lcj-van-den, F. Stalpers, R. Pieters et al., Acute 1435 lymphoblastic leukemia cells create a leukemic niche without affecting the CXCR4/CXCL12 1436 axis, 2017.

J. C. Balandrán, J. Purizaca, J. Enciso, D. Dozal, A. Sandoval et al.,

, Pro-inflammatory-Related Loss of CXCL12 Niche Promotes Acute Lymphoblastic Leukemic 1439 Progression at the Expense of Normal Lymphopoiesis, Front Immunol, vol.7, 1440.

L. C. Cheung, J. Tickner, A. M. Hughes, P. Skut, M. Howlett et al., New 1442 therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment, Leukemia, p.1, 1443.

E. D. Hawkins, D. Duarte, O. Akinduro, R. A. Khorshed, D. Passaro et al., T-1445 cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments, Nature, vol.538, pp.518-540, 1446.

R. N. Kaplan, R. D. Riba, S. Zacharoulis, A. H. Bramley, L. Vincent et al.,

, VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche, Nature, vol.438, pp.820-827, 1449.

A. Hoshino, B. Costa-silva, T. Shen, G. Rodrigues, A. Hashimoto et al.,

, Tumour exosome integrins determine organotropic metastasis, Nature, vol.527, pp.329-364, 1452.

M. Boyiadzis and T. L. Whiteside, The emerging roles of tumor-derived exosomes in 1454 hematological malignancies, Leukemia, vol.31, pp.1259-68, 2017.

S. M. Johnson, C. Dempsey, A. Chadwick, S. Harrison, J. Liu et al., Metabolic 1456 reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute 1457 lymphoblastic leukemia, Blood, vol.128, pp.453-459, 2016.

S. M. Johnson, C. Dempsey, C. Parker, A. Mironov, H. Bradley et al., Acute 1459 lymphoblastic leukaemia cells produce large extracellular vesicles containing organelles and 1460 an active cytoskeleton, J Extracell Vesicles, vol.6, 2017.

M. V. Berridge, M. J. Mcconnell, C. Grasso, M. Bajzikova, J. Kovarova et al., 1462 Horizontal transfer of mitochondria between mammalian cells: beyond co-culture approaches

, Curr Opin Genet Dev, vol.38, pp.75-82, 2016.

R. Polak, . Rooij-b-de, and R. Pieters, Boer ML den. B-cell precursor acute lymphoblastic 1465 leukemia cells use tunneling nanotubes to orchestrate their microenvironment, Blood, vol.1466, pp.2404-2418, 2015.

A. Manabe, E. Coustan-smith, F. G. Behm, S. C. Raimondi, and D. Campana, Bone marrow-1468 derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia, Blood, vol.79, pp.2370-2377, 1469.

D. M. Ashley, S. J. Bol, and G. Kannourakis, Human bone marrow stromal cell contact and 1471 soluble factors have different effects on the survival and proliferation of paediatric B-lineage 1472 acute lymphoblastic leukaemic blasts, Leuk Res, vol.18, pp.337-383, 1994.

N. Shah, L. Oseth, and T. W. Lebien, Development of a Model for Evaluating the Interaction 1474 Between Human Pre-B Acute Lymphoblastic Leukemic Cells and the Bone Marrow Stromal 1475 Cell Microenvironment, Blood, vol.92, pp.3817-3845, 1998.

D. Pal, H. J. Blair, A. Elder, K. Dormon, K. J. Rennie et al., Long-term in 1477 vitro maintenance of clonal abundance and leukaemia-initiating potential in acute 1478 lymphoblastic leukaemia, Leukemia, vol.30, pp.1691-700, 2016.

R. E. Mudry, J. E. Fortney, T. York, B. M. Hall, and L. F. Gibson, Stromal cells regulate survival 1480 of B-lineage leukemic cells during chemotherapy, Blood, vol.96, pp.1926-1958, 2000.

R. Filshie, D. Gottlieb, and K. Bradstock, VLA-4 is involved in the engraftment of the 1482 human pre-B acute lymphoblastic leukaemia cell line NALM-6 in SCID mice, Br J Haematol, vol.1483, pp.1292-300, 1998.

S. Shishido, H. Bönig, and Y. Kim, Role of Integrin Alpha4 in Drug Resistance of, Leukemia. Front Oncol, vol.4, 1485.

T. Krenacs and M. Rosendaal, Connexin43 gap junctions in normal, regenerating, and 1487 cultured mouse bone marrow and in human leukemias: their possible involvement in blood 1488 formation, Am J Pathol, vol.152, pp.993-1004, 1998.

M. Rosendaal, A. Mayen, A. De-koning, T. Dunina-barkovskaya, and T. Krenács, Ploemacher 1490 R. Does transmembrane communication through gap junctions enable stem cells to overcome 1491 stromal inhibition?, Leukemia, vol.11, pp.1281-1290, 1997.

Y. Liu, X. Zhang, Z. Li, and X. Chen, Up-regulation of Cx43 expression and GJIC function 1493 in acute leukemia bone marrow stromal cells post-chemotherapy, Leuk Res, vol.34, pp.631-671, 1494.

X. Zhang, Y. Liu, Y. Si, X. Chen, Z. Li et al., Effect of Cx43 gene-modified 1496 leukemic bone marrow stromal cells on the regulation of Jurkat cell line in vitro, Leuk Res, vol.1497, pp.198-204, 2012.

F. H. Paraguassú-braga, R. Borojevic, L. F. Bouzas, M. A. Barcinski, and A. Bonomo, Bone 1499 marrow stroma inhibits proliferation and apoptosis in leukemic cells through gap junction-1500 mediated cell communication, Cell Death Differ, vol.10, pp.1101-1109, 1501.

M. Sinyuk, A. G. Alvarado, P. Nesmiyanov, J. Shaw, E. E. Mulkearns-hubert et al., Cx25 contributes to leukemia cell communication and chemosensitivity, Oncotarget, vol.1504, pp.31508-31529, 2015.

S. M. Akers, S. L. Rellick, J. E. Fortney, and L. F. Gibson, Cellular elements of the subarachnoid 1506 space promote ALL survival during chemotherapy, Leuk Res, vol.35, pp.705-716, 1507.

M. Pedersen, T. Löfstedt, J. Sun, L. Holmquist-mengelbier, S. Påhlman et al., 1509 Stem cell factor induces HIF-1? at normoxia in hematopoietic cells, Biochem Biophys Res, vol.377, pp.98-103, 1510.

C. M. Ghajar, Metastasis prevention by targeting the dormant niche, Nat Rev Cancer, vol.1512, pp.238-285, 2015.

M. H. Manjili, Tumor Dormancy and Relapse: From a Natural Byproduct of Evolution 1514 to a Disease State, Cancer Res, vol.77, pp.2564-2573, 2017.

M. R. Wick, Metastases of malignant neoplasms: Historical, biological, & clinical 1516 considerations, Semin Diagn Pathol, vol.35, pp.112-134, 2018.

A. E. Groot, R. S. De, J. S. Brown, K. J. Pienta, and S. R. Amend, Revisiting Seed and Soil: 1518 Examining the Primary Tumor and Cancer Cell Foraging in Metastasis, Mol Cancer Res, vol.1519, pp.361-70, 2017.

A. Elder, S. Bomken, I. Wilson, H. J. Blair, S. Cockell et al., Abundant and 1521 equipotent founder cells establish and maintain acute lymphoblastic leukaemia, Leukemia, vol.1522, pp.2577-86, 2017.

M. E. Belderbos, T. Koster, B. Ausema, S. Jacobs, S. Sowdagar et al., Clonal 1524 selection and asymmetric distribution of human leukemia in murine xenografts revealed by 1525 cellular barcoding, Blood, vol.129, pp.3210-3230, 2017.

V. Van-der-velden, D. De-launaij, J. F. De-vries, V. De-haas, E. Sonneveld et al., New cellular markers at diagnosis are associated with isolated central nervous, J Haematol, vol.1529, pp.769-81, 2016.

S. Jeha, D. Pei, S. C. Raimondi, M. Onciu, D. Campana et al., Increased Risk for 1531 CNS Relapse in Pre-B Cell Leukemia with the t(1;19)/TCF3-PBX1, Leuk Off J Leuk Soc Am, p.1532

, Leuk Res Fund UK, vol.23, pp.1406-1415, 2009.

L. Frishman-levy and S. Izraeli, Advances in understanding the pathogenesis of CNS acute 1534 lymphoblastic leukaemia and potential for therapy, Br J Haematol, vol.176, pp.157-67, 1535.

S. Krause, C. Pfeiffer, S. Strube, A. Alsadeq, H. Fedders et al., Mer tyrosine 1537 kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the 1538 central nervous system (CNS), Blood, vol.125, pp.820-850, 2015.

V. Gandemer, A. Rio, M. De-tayrac, V. Sibut, S. Mottier et al., Five 1540 distinct biological processes and 14 differentially expressed genes characterize TEL/AML1-1541 positive leukemia, BMC Genomics, vol.8, p.385, 2007.

V. Gandemer, A. M. Roussel, M. Rio, A. De-tayrac, M. Vallee et al., CD9 1543 expression can be used to predict childhood TEL/AML1-positive acute lymphoblastic 1544 leukemia: proposal for an accelerated diagnostic flowchart, Leuk Res, vol.34, pp.430-437, 1545.

B. Ly-sunnaram, C. Henry, V. Gandemer, F. L. Mee, F. Burtin et al., Late 1547 ovarian relapse of TEL/AML1 positive ALL confirming that TEL deletion is a secondary 1548 event in leukemogenesis, Leuk Res, vol.29, pp.1089-94, 2005.

M. L. Churchman and C. G. Mullighan, Ikaros: Exploiting and targeting the hematopoietic 1550 stem cell niche in B-progenitor acute lymphoblastic leukemia, Exp Hematol, vol.46, 2017.

B. Gerby, D. Veiga, J. Krosl, S. Nourreddine, J. Ouellette et al., High-1553 throughput screening in niche-based assay identifies compounds to target preleukemic stem 1554 cells, J Clin Invest, vol.126, pp.4569-84, 2016.

T. M. Cooper, E. Sison, S. D. Baker, L. Li, A. Ahmed et al., A phase 1 study 1556 of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide 1557 in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A 1558 Pediatric Oncology Experimental Therapeutics Investigators' Consortium study, pp.10-13

, Pediatr Blood Cancer, vol.64, 2017.

S. Randhawa, B. S. Cho, D. Ghosh, M. Sivina, S. Koehrer et al., Effects of 1561 pharmacological and genetic disruption of CXCR4 chemokine receptor function in B-cell 1562 acute lymphoblastic leukaemia, Br J Haematol, vol.174, pp.425-461, 2016.

Y. Hsieh, E. J. Gang, H. Geng, E. Park, S. Huantes et al., Integrin alpha4 1564 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy, Blood, vol.121, pp.1814-1822, 1565.

Y. T. Hsieh, E. J. Gang, S. N. Shishido, H. N. Kim, J. Pham et al., Effects of the 1567 small-molecule inhibitor of integrin ?4, TBC3486, on pre-B-ALL cells, Leukemia, vol.1568, pp.2101-2105, 2014.

A. De-gramont, S. Faivre, and E. Raymond, Novel TGF-? inhibitors ready for prime time in 1570 onco-immunology, Oncoimmunology, vol.6, 2016.

Y. Wang, Y. Liu, S. N. Malek, P. Zheng, and Y. Liu, Targeting HIF1? Eliminates Cancer Stem 1572 Cells in Hematological Malignancies, Cell Stem Cell, vol.8, pp.399-411, 1573.

P. Armand, A. Engert, A. Younes, M. Fanale, A. Santoro et al., Nivolumab 1575 for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous 1576 Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm 1577 Phase II CheckMate 205 Trial, J Clin Oncol, vol.36, pp.1428-1467, 1578.

R. Chen, P. L. Zinzani, M. A. Fanale, A. P. Johnson, N. A. Brice et al., Phase II Study 1580 of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin 1581

. Lymphoma, J Clin Oncol Off J Am Soc Clin Oncol, vol.35, 2017.